CSIMarket
 


Geron Corp  (GERN)
Other Ticker:  
 
 

GERN's Income from Cont. Operations Growth by Quarter and Year

Geron's Income from Cont. Operations results by quarter and year




GERN Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -42.64 -32.02 -23.79
III Quarter September -44.81 -41.05 -26.70 -19.65
II Quarter June -49.23 -28.12 -29.57 -15.82
I Quarter March -38.12 -30.10 -27.82 -16.36
FY   -132.16 -141.91 -116.11 -75.62



GERN Income from Cont. Operations third quarter 2023 Y/Y Growth Comment
Geron Corp in the third quarter 2023 recorded loss from continued operations of $ -44.81 millions.

According to the results reported in the third quarter 2023, Geron Corp achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Geron Corp' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2023.




GERN Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Geron's third quarter 2023 Income from Cont. Operations $ -44.81 millions GERN's Income Statement
Geron's third quarter 2022 Income from Cont. Operations $ -41.05 millions Quarterly GERN's Income Statement
New: More GERN's historic Income from Cont. Operations Growth >>


GERN Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Geron's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GERN's III. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Geron Corp in the III. Quarter 2023 admitted loss from continued operations of $ -44.81 millions, some analyst point out, that this show improvement compare to the -49.23 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Geron Corp achieved highest sequential Income from Cont. Operations growth. While Geron's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


GERN's III. Quarter Q/Q Income from Cont. Operations Comment
Despite the fact, that Geron Corp in the III. Quarter 2023 showed loss from continued operations of $ -44.81 millions, it should be said, that this are recovery relative to the -49.23 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Geron Corp achieved highest sequential Income from Cont. Operations growth. While Geron's Income from Cont. Operations growth quarter on quarter, overall rank is .


Geron's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ -174.79 $ -171.04 $ -149.93 $ -141.90 $ -131.28
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Geron Corp' has realized cumulative trailing twelve months loss from continued operations of $ -175 millions in the Sep 30 2023 period.
The business is detiriorating as the cumulative loss from continued operations is getting bigger from $ -171.04 millions in the twelve months ending a quarter before and $ -116.929 millions for the twelve months ending in the quarter a year ago Catherine Stewart mentioned.

Geron Corp achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Geron Corp' has realized cumulative trailing twelve months loss from continued operations of $ -175 millions in the Sep 30 2023 period.
The business is detiriorating as the cumulative loss from continued operations is becoming larger from $ -171.04 millions in the twelve months ending a quarter before and $ -116.929 millions for the twelve months ending in the quarter a year ago.

Geron Corp achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
GERN's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for GERN's Competitors
Income from Cont. Operations Growth for Geron's Suppliers
Income from Cont. Operations Growth for GERN's Customers

You may also want to know
GERN's Annual Growth Rates GERN's Profitability Ratios GERN's Asset Turnover Ratio GERN's Dividend Growth
GERN's Roe GERN's Valuation Ratios GERN's Financial Strength Ratios GERN's Dividend Payout Ratio
GERN's Roa GERN's Inventory Turnover Ratio GERN's Growth Rates GERN's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2023
Ensign Group Inc13.74%$ 13.737 millions
Zoetis Inc 12.88%$ 12.879 millions
United Therapeutics Corporation11.83%$ 11.826 millions
Edwards Lifesciences Corporation11.70%$ 11.703 millions
Vertex Pharmaceuticals Inc11.26%$ 11.263 millions
Iqvia Holdings Inc 7.07%$ 7.067 millions
Medpace Holdings Inc 6.85%$ 6.850 millions
Prestige Consumer Healthcare Inc 5.41%$ 5.406 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com